Insider trades
Michael B. Hoffman, Chairman of Translational Development Acquisition TDAC, has filed 18 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $4.3M. The latest trade was on 05/27.
Michael B. Hoffman
Chairman and CEO
- First filing
- 23/01/20
- Trades
- 34 trades
- Buys / sales
- 18 / 0
- 12-month net buying
- $4.3M
- Last trade
- 05/27
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANVS | Open-market buy | 05/20 | 05/21 | 76,344 sh3 trades | $1.87avg. | $142,784.4 | +2.3% |
Annovis BioANVS | Open-market buy | 04/02 | 04/03 | 713,800 sh | $2.10 | $1,498,980 | +27.7% |
ANVS | Open-market buy | 25/12/08 | 25/12/08 | 45,000 sh2 trades | $4.31avg. | $193,800 | +1.8% |
ANVS | Open-market buyAmendment | 25/11/24 | 25/11/25 | 78,400 sh8 trades | $4.08avg. | $319,772.14 | +3.2% |
ANVS | Open-market buy | 25/11/21 | 25/11/21 | 20,000 sh2 trades | $3.50avg. | $69,900 | +0.8% |
Annovis BioANVS | Open-market buy | 25/11/14 | 25/11/18 | 15,000 sh | $2.11 | $31,650 | +0.6% |
Annovis BioANVS | Open-market buy | 25/10/28 | 25/11/12 | 975,610 sh | $2.05 | $2,000,000.5 | +65.9% |
